Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central ...

Good morning, and welcome to the Axsome Therapeutics' fourth quarter and full year 2024 conference call. Currently, all participants are in listen-only mode. Later, there will be a question-and ...

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of ...

68 analyst firms have reported ratings in the last year. The last upgrade for Axsome Therapeutics Inc happened on August 6, 2024 when B of A Securities raised their price target to $106.

State of New Jersey Common Pension Fund D decreased its stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 1.9% during the 4th quarter, HoldingsChannel reports. The firm owned ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders ...

Dr. Roger A. Jeffs is a Chief Executive Officer & Director at Liquidia Corp., a Vice Chairman at Kriya Therapeutics, Inc., a Lead Independent Director at Axsome Therapeutics, Inc. and a Co-Owner ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Axsome Therapeutics Inc. Annual stock financials by MarketWatch. View the latest 0HKF financial statements, income statements and financial ratios. Skip to main content Main Menu Latest News Watchlist ...